Literature DB >> 15721010

Sterol-regulatory-element binding protein inhibits upstream stimulatory factor-stimulated hepatic lipase gene expression.

Gert-Jan Botma1, Diederik van Deursen, Delfina Vieira, Mandy van Hoek, Hans Jansen, Adrie J M Verhoeven.   

Abstract

Hepatic lipase (HL) not only plays an important role in plasma lipoprotein transport, but may also affect intracellular lipid metabolism. We hypothesize that HL expression is regulated as an integral part of intracellular lipid homeostasis. Addition of oleate (1 mM) to HepG2 cells increased HL secretion to 134+/-14% of control (p<0.02), and increased the transcriptional activity of a 698-bp HL promoter-reporter construct two-fold. Atorvastatin (10 microM) abolished the oleate stimulation. The transcriptional activity of a sterol-regulatory-element binding protein (SREBP)-sensitive HMG-CoA synthase promoter construct was reduced 50% by oleate, and increased 2-3-fold by atorvastatin. Co-transfection with an SREBP-2 expression vector reduced HL promoter activity and increased HMG-CoA synthase promoter activity. Upstream stimulatory factors (USF) are also implicated in maintenance of lipid homeostasis. Co-transfection with a USF-1 expression vector stimulated HL promoter activity 4-6-fold. The USF-stimulated HL promoter activity was not further enhanced by oleate, but almost completely prevented by atorvastatin or co-transfection with the SREBP-2 vector. Opposite regulation by USF-1 and SREBP-2 was also observed with a 318-bp HL promoter construct that lacks potential SRE-like and E-box binding motifs. We conclude that the opposite regulation of HL expression by fatty acids and statins is mediated via SREBP, possibly through interaction with USF.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15721010     DOI: 10.1016/j.atherosclerosis.2004.10.027

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  5 in total

1.  Upstream transcription factor 1 gene polymorphisms are associated with high antilipolytic insulin sensitivity and show gene-gene interactions.

Authors:  Konstantinos Kantartzis; Andreas Fritsche; Fausto Machicao; Michael Stumvoll; Jürgen Machann; Fritz Schick; Hans-Ulrich Häring; Norbert Stefan
Journal:  J Mol Med (Berl)       Date:  2006-09-26       Impact factor: 4.599

2.  Glucose increases hepatic lipase expression in HepG2 liver cells through upregulation of upstream stimulatory factors 1 and 2.

Authors:  D van Deursen; H Jansen; A J M Verhoeven
Journal:  Diabetologia       Date:  2008-08-30       Impact factor: 10.122

3.  Activation of hepatic lipase expression by oleic acid: possible involvement of USF1.

Authors:  Diederik van Deursen; Marije van Leeuwen; Deniz Akdogan; Hadie Adams; Hans Jansen; Adrie J M Verhoeven
Journal:  Nutrients       Date:  2009-10-29       Impact factor: 5.717

4.  The Proline 7 Substitution in the Preproneuropeptide Y Is Associated with Higher Hepatic Lipase Activity In Vivo.

Authors:  Stephan Schiekofer; Marcus E Kleber; Winfried Maerz; Franz M Rasche; Jochen G Schneider
Journal:  Int J Endocrinol       Date:  2017-05-30       Impact factor: 3.257

5.  Comparative genomics and experimental promoter analysis reveal functional liver-specific elements in mammalian hepatic lipase genes.

Authors:  Diederik van Deursen; Gert-Jan Botma; Hans Jansen; Adrie J M Verhoeven
Journal:  BMC Genomics       Date:  2007-04-11       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.